2 lawyers who rejected $9.5M attorney fee in Prempro case will get $21.8M
By EsqSocial Corporation 23/07/14
Two lead lawyers in long-running litigation over Pfizer's Inc.'s Prempro menopause drug have more than doubled their own payout by challenging a plan to allocate them less than $10 million of a $62 million common-benefit fund for attorney fees. Federal court filings in Little Rock, Arkansas, say fellow plaintiffs lawyers…